Clinical Trials Directory

Trials / Completed

CompletedNCT03874104

Synbiotic Extensively Hydrolysed Feed Study

An Evaluation of the Tolerance and Acceptability of a Whey-based Extensively Hydrolysed Feed With Pre- and Probiotics, for the Dietary Management of Cows' Milk Allergy in Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Nutricia UK Ltd · Industry
Sex
All
Age
13 Months
Healthy volunteers
Not accepted

Summary

This study of the tolerance and acceptability of a extensively hydrolysed formula (eHF) containing pre- and probiotics will assess gastrointestinal (GI) tolerance, product intake and acceptability in 40 infants (aged \<13 months) currently using or requiring an extensively hydrolysed formula for the dietary management of CMA. Patients already prescribed an eHF (or other appropriate feed for CMA) at time of recruitment will undertake a 3 day baseline period in which their current symptoms, compliance, GI tolerance and acceptability towards their current feed is assessed, before introducing the study product for a period of 4 weeks. Patients who are not on an eHF (or other appropriate feed for CMA) at baseline will forgo this 3 day baseline period and immediately introduce the study product for 4 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExtensively Hydrolysed Formula containing Pre- & ProbioticsExtensively Hydrolysed Formula containing Pre- and Probiotics

Timeline

Start date
2018-08-22
Primary completion
2021-12-01
Completion
2023-07-31
First posted
2019-03-14
Last updated
2023-11-27

Locations

8 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03874104. Inclusion in this directory is not an endorsement.